Position statement of the Spanish Society of Nephrology on the SARS-CoV-2 vaccines.
Nefrologia (Engl Ed)
; 41(4): 412-416, 2021.
Article
in English
| MEDLINE | ID: covidwho-2105644
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread worldwide over the last year causing more than one million deaths. Several treatments have tried to modify the natural history of the coronavirus disease 2019 (COVID-19) but only corticosteroids have demonstrated to be effective in moderate or severe affectation. In that situation, the development of vaccines for preventing the SARS-CoV-2 infection has focused the attention of the scientific community. At present, available messenger RNA-based technology vaccines have received the approval of local and international sanitary authorities. In this position statement, the Spanish Society of Nephrology wants to state that patients with chronic kidney disease and healthcare workers are at high-risk for contagion and complications of COVID-19 so they must have priority in the vaccine administration.
Keywords
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Vaccines
/
COVID-19
/
Nephrology
Type of study:
Prognostic study
Topics:
Vaccines
Limits:
Humans
Language:
English
Journal:
Nefrologia (Engl Ed)
Year:
2021
Document Type:
Article
Affiliation country:
J.nefroe.2021.09.001
Similar
MEDLINE
...
LILACS
LIS